Impact of body mass index on the efficacy of aromatase inhibitors in patients with metastatic breast cancer

被引：0
|
作者：
Rima Patel
Zhiqiang Li
Brittney S. Zimmerman
Marc Y. Fink
Jason D. Wells
Xiang Zhou
Kristin Ayers
Arielle Redfern
Scott Newman
Eric Schadt
William K. Oh
Rong Chen
Amy Tiersten
机构：
[1] Icahn School of Medicine at Mount Sinai,Division of Hematology and Medical Oncology
[2] Sema4,undefined
来源：
Breast Cancer Research and Treatment | 2022年 / 192卷
关键词：
Metastatic breast cancer; Obesity; Aromatase inhibitors; Hormone positive breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：313 / 319
页数：6
相关论文
共 50 条
  • [31] Impact of Body Mass Index on Breast Cancer Subtypes in Iranian Women
    Ahmadi, Hamid
    Eslami, Bita
    Alipour, Sadaf
    Yazdankhahkenary, Adel
    Omranipour, Ramesh
    CLINICAL CANCER INVESTIGATION JOURNAL, 2019, 8 (02): : 52 - 56
  • [32] Impact of body mass index on clinico-pathological parameters and outcome in patients with metastatic prostate cancer
    Mohammed, Amrallah A.
    El-Tanni, Hani
    Ghanem, Hafez M.
    Farooq, Mian U.
    El Saify, Amr M.
    Al-Zahrani, Abdullah S.
    EL-Shentenawy, Ayman
    El-Khatib, Hani M.
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2015, 27 (03) : 155 - 159
  • [33] Aromatase Inhibitors for Ovarian Stimulation in Patients with Breast Cancer
    Ferreiro, Esteban
    Lopez de Uralde, Belen
    Abreu, Rita
    Garcia-Velasco, Juan A.
    Munoz, Elkin
    CURRENT DRUG TARGETS, 2020, 21 (09) : 910 - 921
  • [34] Aromatase inhibitors and breast cancer
    Chumsri, Saranya
    Brodie, Angela
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2012, 9 (02) : 119 - 126
  • [35] Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer
    Jammallo, Lauren S.
    Miller, Cynthia L.
    Singer, Marybeth
    Horick, Nora K.
    Skolny, Melissa N.
    Specht, Michelle C.
    O'Toole, Jean
    Taghian, Alphonse G.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 142 (01) : 59 - 67
  • [36] AROMATASE INHIBITORS: A NEW HOPE FOR BREAST CANCER PATIENTS
    Mahajan, Anu
    Rawal, Shruti
    Bedi, P. M. S.
    Mahajan, Nipun
    Sharma, Ajay
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2010, 1 (06): : 27 - 40
  • [37] Aromatase inhibitors in breast cancer
    Hiscox, Stephen
    Davies, Eleri Lloyd
    Barrett-Lee, Peter
    MATURITAS, 2009, 63 (04) : 275 - 279
  • [38] Relationship between body mass index and preoperative treatment response to aromatase inhibitor exemestane in postmenopausal patients with primary breast cancer
    Takada, Masahiro
    Saji, Shigehira
    Masuda, Norikazu
    Kuroi, Katsumasa
    Sato, Nobuaki
    Takei, Hiroyuki
    Yamamoto, Yutaka
    Ohno, Shinji
    Yamashita, Hiroko
    Hisamatsu, Kazufumi
    Aogi, Kenjiro
    Iwata, Hiroji
    Ueno, Takayuki
    Sasano, Hironobu
    Toi, Masakazu
    BREAST, 2012, 21 (01) : 40 - 45
  • [39] Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial
    Pfeiler, Georg
    Koenigsberg, Robert
    Fesl, Christian
    Mlineritsch, Brigitte
    Stoeger, Herbert
    Singer, Christian F.
    Poestlberger, Sabine
    Steger, Guenther G.
    Seifert, Michael
    Dubsky, Peter
    Taucher, Susanne
    Samonigg, Hellmut
    Bjelic-Radisic, Vesna
    Greil, Richard
    Marth, Christian
    Gnant, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (19) : 2653 - 2659
  • [40] Long-term effects of aromatase inhibitors on body mass index among postmenopausal breast cancer survivors in Africa: observational cohort study
    Jean Paul Muambangu Milambo
    Peter S Nyasulu
    John M Akudugu
    James Ndirangu
    BMC Research Notes, 16
12345